MX2010000856A - Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma. - Google Patents

Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.

Info

Publication number
MX2010000856A
MX2010000856A MX2010000856A MX2010000856A MX2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A
Authority
MX
Mexico
Prior art keywords
preparation
calcium channel
channel antagonist
pharmaceutical composition
composition containing
Prior art date
Application number
MX2010000856A
Other languages
English (en)
Spanish (es)
Inventor
Evangelos Karavas
Efthimios Koutris
Ioanna Koutri
Eleni Sthathaki
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39223083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010000856(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of MX2010000856A publication Critical patent/MX2010000856A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
MX2010000856A 2007-07-23 2007-07-23 Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma. MX2010000856A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/006517 WO2009012791A1 (en) 2007-07-23 2007-07-23 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Publications (1)

Publication Number Publication Date
MX2010000856A true MX2010000856A (es) 2010-04-30

Family

ID=39223083

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2010000856A MX2010000856A (es) 2007-07-23 2007-07-23 Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.
MX2010000801A MX2010000801A (es) 2007-07-23 2008-07-23 Composicion farmaceutica mejorada que contiene antagonista de canal de calcio de dihidropiridina y metodo para su preparacion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2010000801A MX2010000801A (es) 2007-07-23 2008-07-23 Composicion farmaceutica mejorada que contiene antagonista de canal de calcio de dihidropiridina y metodo para su preparacion.

Country Status (20)

Country Link
EP (2) EP2180883B1 (enExample)
JP (2) JP5769963B2 (enExample)
KR (2) KR101632079B1 (enExample)
CN (3) CN101784260A (enExample)
AU (2) AU2007356942B2 (enExample)
BR (2) BRPI0721883A2 (enExample)
CA (2) CA2691752C (enExample)
CO (1) CO6290639A2 (enExample)
CR (1) CR11285A (enExample)
EA (2) EA021645B1 (enExample)
EC (1) ECSP109984A (enExample)
ES (2) ES2622495T3 (enExample)
MA (1) MA31684B1 (enExample)
MX (2) MX2010000856A (enExample)
MY (1) MY153857A (enExample)
NZ (2) NZ582648A (enExample)
TN (2) TN2010000011A1 (enExample)
UA (2) UA97161C2 (enExample)
WO (2) WO2009012791A1 (enExample)
ZA (2) ZA201000586B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
JP2010533729A (ja) 2007-07-17 2010-10-28 プレキシコン，インコーポレーテッド キナーゼ調節のための化合物と方法、及びそのための適応
KR101632079B1 (ko) * 2007-07-23 2016-06-20 파마덴 에스.에이. 디히드로피리딘 칼슘 채널 길항제를 함유하는 약제학적 조성물 및 그것의 제조방법
CA2738573C (en) 2009-04-03 2013-02-19 F. Hoffmann-La Roche Ag Compositions of propane-1 sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide and uses thereof
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
JP2013510166A (ja) 2009-11-06 2013-03-21 プレキシコン インコーポレーテッド キナーゼ調節のための化合物、方法およびその適用
PE20141360A1 (es) 2011-02-07 2014-10-13 Plexxikon Inc Compuestos y metodos para la modulacion de quinasas e indicaciones para los mismos.
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
GR1008554B (el) * 2014-06-12 2015-09-03 ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ, Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου
CN104069500A (zh) * 2014-06-20 2014-10-01 湖南天地恒一制药有限公司 一种包含乐卡地平的药物组合物
CN105168165B (zh) * 2015-08-28 2018-06-26 江苏福邦药业有限公司 一种盐酸乐卡地平片及其制备方法
WO2018004379A1 (ru) * 2016-07-01 2018-01-04 Общество С Ограниченной Ответственностью "Гиостин" Средство в виде капсулы для лечения заболеваний суставов
WO2019165420A1 (en) 2018-02-26 2019-08-29 R.P. Scherer Technologies, Llc Pharmaceutical dosage form for an emulsion of simethicone and loperamide
CA3094115A1 (en) 2018-03-22 2019-09-26 Komipharm International Australia Pty Ltd Pharmaceutical composition comprising meta arsenite and method of manufacture
JP2023107429A (ja) * 2022-01-24 2023-08-03 東芝テック株式会社 読取装置
CN114533686B (zh) * 2022-02-15 2023-10-20 湖南普道医药技术有限公司 一种二氢吡啶类药物的口服固体制剂及其制备方法
KR20240040407A (ko) * 2022-09-21 2024-03-28 주식회사 종근당 사쿠비트릴ㆍ발사르탄 칼슘염을 포함하는 약제학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
BR9903490A (pt) * 1998-12-15 2000-09-26 Oscar Gold Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
DE19944803A1 (de) * 1999-09-20 2001-03-29 Bayer Ag Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof
EP1694305B1 (en) * 2003-12-01 2019-10-16 Recordati Ireland Limited Pharmaceutical compositions comprising lercanidipine
UA89177C2 (ru) * 2003-12-01 2010-01-11 Рекордати Айрленд Лимитед Фармацевтическая композиция с контролируемым высвобождением, которая содержит лерканидипин
EP2063872B2 (en) * 2006-08-30 2019-12-04 Jagotec AG Controlled release oral dosage formulations comprising a core and one or more barrier layers
WO2008068777A2 (en) * 2006-12-06 2008-06-12 Torrent Pharmaceuticals Limited Stable lercanidipine formulation
KR101632079B1 (ko) * 2007-07-23 2016-06-20 파마덴 에스.에이. 디히드로피리딘 칼슘 채널 길항제를 함유하는 약제학적 조성물 및 그것의 제조방법

Also Published As

Publication number Publication date
EP2170295A1 (en) 2010-04-07
ZA201000586B (en) 2011-03-30
NZ582690A (en) 2011-12-22
EP2180883B1 (en) 2017-01-11
BRPI0721883A2 (pt) 2014-02-18
CN103976968A (zh) 2014-08-13
AU2008280106A1 (en) 2009-01-29
NZ582648A (en) 2012-06-29
JP5769963B2 (ja) 2015-08-26
CA2691752C (en) 2016-01-26
CR11285A (es) 2010-04-27
KR20100047848A (ko) 2010-05-10
CA2691752A1 (en) 2009-01-29
ES2537063T3 (es) 2015-06-02
ZA201001176B (en) 2010-11-24
UA97161C2 (ru) 2012-01-10
MA31684B1 (fr) 2010-09-01
ECSP109984A (es) 2010-04-30
AU2008280106B2 (en) 2014-03-20
WO2009012791A1 (en) 2009-01-29
TN2010000022A1 (en) 2011-09-26
AU2008280106A2 (en) 2010-02-25
TN2010000011A1 (en) 2011-09-26
EP2170295B1 (en) 2015-04-22
CN101784260A (zh) 2010-07-21
CO6290639A2 (es) 2011-06-20
AU2007356942A1 (en) 2009-01-29
EA201070160A1 (ru) 2010-06-30
CN101801347A (zh) 2010-08-11
KR20100045456A (ko) 2010-05-03
MY153857A (en) 2015-03-31
CA2693233A1 (en) 2009-01-29
EP2180883A1 (en) 2010-05-05
EA019614B1 (ru) 2014-05-30
EA021645B1 (ru) 2015-08-31
KR101512404B1 (ko) 2015-04-21
WO2009013306A1 (en) 2009-01-29
EA201000220A1 (ru) 2010-08-30
KR101632079B1 (ko) 2016-06-20
ES2622495T3 (es) 2017-07-06
AU2007356942B2 (en) 2011-12-15
BRPI0814666A2 (pt) 2017-05-09
JP2010534211A (ja) 2010-11-04
JP2010534220A (ja) 2010-11-04
UA99136C2 (ru) 2012-07-25
MX2010000801A (es) 2010-07-05
AU2008280106B9 (en) 2014-08-07

Similar Documents

Publication Publication Date Title
TN2010000022A1 (en) Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
CR11137A (es) Valvulas prosteticas de corazon
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
BR112012023780A2 (pt) compostos complexos de ferro (iii) - b - cetoamida ou sais farmaceuticamente toleráveis desses, processo para a produção dos compostos complexos de ferro (iii), uso de compostos complexos de ferro (iii), fármaco contendo compostos complexos de ferro (iii) e composição contendo compostos complexos de ferro (iii)
WO2014016754A3 (en) Pharmaceutical compositions of proton pump inhibitor
PH12017501397B1 (en) (2s, 4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor
ZA201003380B (en) Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
WO2009084036A3 (en) Composition for treatment of viral infections
WO2007110765A3 (en) Processes for the preparation of octreotide
GR1008821B (el) Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου
MX2007010400A (es) Nuevas sales de derivados de hexahidrofenantridina sustituida con 6-heterociclilo.
WO2010061220A3 (en) Novel processes and pure polymorphs
GR20070100405A (el) Βελτιωμενες φαρμακοτεχνικες μορφες που περιεχουν αναστολεις της ακετυλοχοληνεστερασης και μεθοδοι παρασκευης αυτων
EA201190282A1 (ru) Фармацевтическая композиция, содержащая тамсулозин
MY150480A (en) Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
WO2011086577A3 (en) Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
PL401632A1 (pl) Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
CY1108846T1 (el) Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της
WO2010061219A3 (en) Polymorphs
WO2010046912A3 (en) Thiophene containing analogues of fluconazole as antifungal agents and process for their preparation
WO2007052167A3 (en) Stable composition for a pharmaceutical formulation containing olanzapine
CO6260055A2 (es) Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma
WO2014141298A3 (en) Stable pharmaceutical composition of fingolimod
GR1007741B (el) Φαρμακευτικο σκευασμα περιεχον εναν ατυπικο αντιψυχωτικο παραγοντα και μεθοδος για την παρασκευη αυτου

Legal Events

Date Code Title Description
FG Grant or registration